Delay on Moderna Shots for Children 5–11 Not Expected to Affect Vaccination Rollout: White House

Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention, is seen in Washington in a file photograph. Greg Nash/Pool/Getty Images

Drug regulators delaying a decision on whether or not to authorize Moderna’s COVID-19 vaccine for children won’t affect the rollout of jabs for children as young as 5, Biden administration officials said Monday.

The Biden administration has secured enough of Pfizer’s vaccine to vaccinate every child between 5 and 11, Jeffrey Zients, the White House’s COVID-19 response coordinator, told reporters in a briefing.